OpenURL Connection Search

Select item for more details and to access through your institution.

Distinct karyotypic and mutational landscape in trisomy AML.
Published in:
British Journal of Haematology, 2024, v. 204, n. 3, p. 939, doi. 10.1111/bjh.19249
By:
- Lam, Stephen S. Y.;
- Tsui, Sze P.;
- Fung, C. Y.;
- Saw, Nicole Y.;
- Javed, Asif;
- Ip, Alvin H. W.;
- Ma, Edmond S. K.;
- Leung, Anskar Y. H.
Publication type:
Article
Cell adhesion manipulation through single cell assembly for characterization of initial cell-to-cell interaction.
Published in:
2015
By:
- Xue Gou;
- Ran Wang;
- Lam, Stephen S. Y.;
- Jundi Hou;
- Leung, Anskar Y. H.;
- Dong Sun;
- Gou, Xue;
- Wang, Ran;
- Hou, Jundi;
- Sun, Dong
Publication type:
journal article
Homoharringtonine (omacetaxine mepesuccinate) as an adjunct for FLT3-ITD acute myeloid leukemia.
Published in:
Science Translational Medicine, 2016, v. 8, n. 359, p. 1, doi. 10.1126/scitranslmed.aaf3735
By:
- Lam, Stephen S. Y.;
- Ho, Eric S. K.;
- Bai-Liang He;
- Wui-Wing Wong;
- Chae-Yin Cher;
- Ng, Nelson K. L.;
- Cheuk-Him Man;
- Gill, Harinder;
- Cheung, Alice M. S.;
- Ho-Wan Ip;
- Chi-Chiu So;
- Jerome Tamburini;
- Chi Wai Eric So;
- Ho, Dona N.;
- Chun-Hang Au;
- Tsun-Leung Chan;
- Ma, Edmond S. K.;
- Liang, Raymond;
- Yok-Lam Kwong;
- Leung, Anskar Y. H.
Publication type:
Article
Distinct mutation spectrum, clinical outcome and therapeutic responses of typical complex/monosomy karyotype acute myeloid leukemia carrying TP53 mutations.
Published in:
American Journal of Hematology, 2019, v. 94, n. 6, p. 650, doi. 10.1002/ajh.25469
By:
- Leung, Garret M. K.;
- Zhang, Chunxiao;
- Ng, Nelson K. L.;
- Yang, Ning;
- Lam, Stephen S. Y.;
- Au, Chun H.;
- Chan, Tsun L.;
- Ma, Edmond S. K.;
- Tsui, Sze P.;
- Ip, Ho W.;
- So, Jason C. C.;
- Ng, Margaret H. L.;
- Cheng, Kelvin C. K.;
- Wong, Kit F.;
- Siu, Lisa L. P.;
- Yip, Sze F.;
- Lin, Shek Y.;
- Lau, June S. M.;
- Luk, Tsan H.;
- Lee, Harold K. K.
Publication type:
Article
Sorafenib and omacetaxine mepesuccinate as a safe and effective treatment for acute myeloid leukemia carrying internal tandem duplication of Fms-like tyrosine kinase 3.
Published in:
2020
By:
- Zhang, Chunxiao;
- Lam, Stephen S. Y.;
- Leung, Garret M. K.;
- Tsui, Sze‐Pui;
- Yang, Ning;
- Ng, Nelson K. L.;
- Ip, Ho‐Wan;
- Au, Chun‐Hang;
- Chan, Tsun‐Leung;
- Ma, Edmond S. K.;
- Yip, Sze‐Fai;
- Lee, Harold K. K.;
- Lau, June S. M.;
- Luk, Tsan‐Hei;
- Li, Wa;
- Kwong, Yok‐Lam;
- Leung, Anskar Y. H.;
- Tsui, Sze-Pui;
- Ip, Ho-Wan;
- Au, Chun-Hang
Publication type:
journal article

Found: 5

Distinct karyotypic and mutational landscape in trisomy AML.

Cell adhesion manipulation through single cell assembly for characterization of initial cell-to-cell interaction.

Homoharringtonine (omacetaxine mepesuccinate) as an adjunct for FLT3-ITD acute myeloid leukemia.

Distinct mutation spectrum, clinical outcome and therapeutic responses of typical complex/monosomy karyotype acute myeloid leukemia carrying TP53 mutations.

Sorafenib and omacetaxine mepesuccinate as a safe and effective treatment for acute myeloid leukemia carrying internal tandem duplication of Fms-like tyrosine kinase 3.